Securities code: 000806 securities abbreviation: St Galaxy Announcement No.: 2021-114
Galaxy Biomedical Investment Co.Ltd(000806)
Some shares held by controlling shareholders will be auctioned by the judiciary
Suggestive announcement
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Galaxy Biomedical Investment Co.Ltd(000806) (hereinafter referred to as “the company”) recently learned from the Taobao judicial auction platform that 111989400 shares of the company held by the controlling shareholder of the company, Galaxy Tiancheng Group Co., Ltd. (hereinafter referred to as “Galaxy Group”) will be auctioned. The details are as follows:
1、 Main contents of judicial auction
With regard to the notarization of creditor’s rights documents between Huarong Securities Co., Ltd. (hereinafter referred to as “Huarong securities”) and Galaxy Group, Shenzhen intermediate people’s court has made a ruling to auction and sell off 111989400 Pledged Shares held by Galaxy Group (9999400 restricted shares and 1199000 non tradable shares after the IPO) to pay off the debt. The above shares will be auctioned on Taobao Shenzhen intermediate people’s Court judicial auction platform on January 25, 2022（ http://sf.taobao.com./0755/03 ）For the first online public auction, see the auction announcement of Shenzhen intermediate people’s Court on Taobao judicial auction platform for relevant matters.
2、 Other information
1. As of the disclosure date of this announcement, Galaxy Group holds 261803141 shares of the company, accounting for 23.80% of the total share capital of the company. Its shares of the company have been subject to judicial freezing and waiting for freezing.
2. The 111989400 shares to be auctioned by the judiciary account for 42.78% of the total shares of the company held by Galaxy Group and 10.18% of the total share capital of the company. If the judicial auction is successfully implemented, the shares of the company held by Galaxy Group will be reduced to 149813741 shares, accounting for 13.62% of the total shares of the company. It is still the controlling shareholder of the company, and the controlling shareholder and actual controller of the company will not change.
3. The subsequent auction will involve auction, payment, equity change transfer and other links. The auction results are still uncertain. The company will pay close attention to the subsequent progress of the matter and fulfill the obligation of information disclosure in time according to the provisions and requirements of relevant laws and regulations.
3、 Auction risk tips
The 9999400 restricted shares in this auction have damaged the interests of the listed company due to the non operating capital occupation and illegal guarantee of the listed company by the shareholder Galaxy Group, and the damage has not been eliminated, The new shareholders who finally won the auction do not meet the conditions for lifting the restrictions on the sale of restricted shares in accordance with the business guidelines for listed companies of Shenzhen Stock Exchange No. 7 – lifting the restrictions on the sale of restricted shares and other relevant provisions, and may not entrust the company to apply to Shenzhen Stock exchange for handling the relevant procedures for lifting the restrictions on the sale of their shares.
It is hereby announced.
Galaxy Biomedical Investment Co.Ltd(000806) board of directors
December 23, 2001
